Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Peraso (PRSO) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Peraso (PRSO) over the last 15 years, with Q3 2025 value amounting to $152000.0.

  • Peraso's Other Accumulated Expenses fell 9366.4% to $152000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $152000.0, marking a year-over-year decrease of 9366.4%. This contributed to the annual value of $37000.0 for FY2024, which is 9394.44% down from last year.
  • Latest data reveals that Peraso reported Other Accumulated Expenses of $152000.0 as of Q3 2025, which was down 9366.4% from $74000.0 recorded in Q2 2025.
  • Peraso's Other Accumulated Expenses' 5-year high stood at $2.4 million during Q3 2024, with a 5-year trough of $1000.0 in Q4 2021.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $175500.0 (2025), whereas its average is $475375.0.
  • Per our database at Business Quant, Peraso's Other Accumulated Expenses plummeted by 9931.03% in 2021 and then soared by 3290000.0% in 2022.
  • Peraso's Other Accumulated Expenses (Quarter) stood at $1000.0 in 2021, then skyrocketed by 32900.0% to $330000.0 in 2022, then soared by 85.15% to $611000.0 in 2023, then plummeted by 93.94% to $37000.0 in 2024, then soared by 310.81% to $152000.0 in 2025.
  • Its last three reported values are $152000.0 in Q3 2025, $74000.0 for Q2 2025, and $199000.0 during Q1 2025.